» Articles » PMID: 34210002

Interactions Between Apolipoprotein E Metabolism and Retinal Inflammation in Age-Related Macular Degeneration

Overview
Journal Life (Basel)
Specialty Biology
Date 2021 Jul 2
PMID 34210002
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Age-related macular degeneration (AMD) is a multifactorial retinal disorder that is a major global cause of severe visual impairment. The development of an effective therapy to treat geographic atrophy, the predominant form of AMD, remains elusive due to the incomplete understanding of its pathogenesis. Central to AMD diagnosis and pathology are the hallmark lipid and proteinaceous deposits, drusen and reticular pseudodrusen, that accumulate in the subretinal pigment epithelium and subretinal spaces, respectively. Age-related changes and environmental stressors, such as smoking and a high-fat diet, are believed to interact with the many genetic risk variants that have been identified in several major biochemical pathways, including lipoprotein metabolism and the complement system. The gene, encoding apolipoprotein E (APOE), is a major genetic risk factor for AMD, with the allele conferring increased risk and conferring reduced risk, in comparison to the wildtype . Paradoxically, is the main genetic risk factor in Alzheimer's disease, a disease with features of neuroinflammation and amyloid-beta deposition in common with AMD. The potential interactions of APOE with the complement system and amyloid-beta are discussed here to shed light on their roles in AMD pathogenesis, including in drusen biogenesis, immune cell activation and recruitment, and retinal inflammation.

Citing Articles

Mesenchymal stem cell-derived exosomes mitigate amyloid β-induced retinal toxicity: Insights from rat model and cellular studies.

Qarawani A, Naaman E, Ben-Zvi Elimelech R, Harel M, Sigal-Dror S, Ben-Zur T J Extracell Biol. 2025; 4(1):e70024.

PMID: 39844926 PMC: 11752158. DOI: 10.1002/jex2.70024.


The Potential Causal Association of Apolipoprotein A and B and Age-Related Macular Degeneration: A Mendelian Randomisation Study.

Lee Y, Seo J Biomedicines. 2025; 12(12.

PMID: 39767734 PMC: 11673427. DOI: 10.3390/biomedicines12122828.


Nutritional Genomics: Implications for Age-Related Macular Degeneration.

Figueiredo I, Farinha C, Barreto P, Coimbra R, Pereira P, Marques J Nutrients. 2024; 16(23).

PMID: 39683519 PMC: 11643977. DOI: 10.3390/nu16234124.


Applying low levels of strain to model nascent phenomenon of retinal pathologies.

Paterson C, Vargis E Lab Chip. 2024; 24(24):5338-5346.

PMID: 39575534 PMC: 11884429. DOI: 10.1039/d4lc00205a.


Genetic Insights into Age-Related Macular Degeneration.

Bhumika , Bora N, Bora P Biomedicines. 2024; 12(7).

PMID: 39062052 PMC: 11274963. DOI: 10.3390/biomedicines12071479.


References
1.
Phillips M . Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life. 2014; 66(9):616-23. DOI: 10.1002/iub.1314. View

2.
Liu R, Wang A, To E, Gao J, Cao S, Cui J . Vinpocetine inhibits amyloid-beta induced activation of NF-κB, NLRP3 inflammasome and cytokine production in retinal pigment epithelial cells. Exp Eye Res. 2014; 127:49-58. PMC: 4461375. DOI: 10.1016/j.exer.2014.07.003. View

3.
Hoh Kam J, Lenassi E, Jeffery G . Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages. PLoS One. 2010; 5(10). PMC: 2948519. DOI: 10.1371/journal.pone.0013127. View

4.
Pang C, Baum L, Chan W, Lau T, Poon P, Lam D . The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica. 2000; 214(4):289-91. DOI: 10.1159/000027506. View

5.
Mckay G, Patterson C, Chakravarthy U, Dasari S, Klaver C, Vingerling J . Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat. 2011; 32(12):1407-16. PMC: 3217135. DOI: 10.1002/humu.21577. View